SynthesisRheumatology (Oxford, England)2026
First-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes.
Mark D Russell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.